Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
21 12 2022
Historique:
pubmed: 3 11 2022
medline: 28 12 2022
entrez: 2 11 2022
Statut: ppublish

Résumé

This study aimed to assess the proportion of carbapenemase-producing Enterobacterales (CPE) infections among all infectious episodes in CPE carriers, compare the time-to-onset of CPE infections with that of other infections, assess the mortality of patients with CPE infections, and identify risk factors for CPE infections in CPE carriers. A retrospective cohort study was performed over a 10-year period in our University Hospital, and 274 CPE carriers were identified. All infectious episodes within the first 6 months following the diagnosis of CPE rectal carriage were considered. Risk factor analysis for CPE infections in CPE carriers was performed by univariate and multivariate analyses. This study revealed an incidence of 24.1% (66/274) of CPE infection within 6 months of CPE carriage diagnosis. The 28-day all-cause mortality due to CPE infections was 25.7%. CPE infections represented 52.6% (70/133) of all infectious episodes in CPE carriers in the first 6 months following CPE carriage detection, and these significantly occurred earlier than non-CPE infections, with a median time of 15 versus 51 days, respectively (

Identifiants

pubmed: 36321906
doi: 10.1128/spectrum.01868-22
pmc: PMC9769894
doi:

Substances chimiques

carbapenemase EC 3.5.2.6
beta-Lactamases EC 3.5.2.6
Bacterial Proteins 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0186822

Références

Am J Infect Control. 2012 Jun;40(5):421-5
pubmed: 21906844
Clin Microbiol Infect. 2001 Apr;7(4):173-8
pubmed: 11422238
Clin Infect Dis. 2015 Aug 15;61(4):593-600
pubmed: 25904368
Intensive Care Med. 2015 Jan;41(1):34-48
pubmed: 25427866
Clin Infect Dis. 2021 Nov 2;73(9):1664-1676
pubmed: 33618353
Clin Microbiol Infect. 2013 Feb;19(2):E72-9
pubmed: 23231088
Infect Dis Ther. 2018 Dec;7(4):439-455
pubmed: 30270406
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28559250
Am J Infect Control. 2016 May 1;44(5):539-43
pubmed: 26899297
J Infect. 2018 May;76(5):438-448
pubmed: 29477802
J Hosp Infect. 2016 Oct;94(2):125-9
pubmed: 27542962
Clin Microbiol Infect. 2011 Aug;17(8):1135-41
pubmed: 21635663
Clin Microbiol Infect. 2014 Dec;20(12):1357-62
pubmed: 24980276
Clin Microbiol Infect. 2022 Apr;28(4):465-469
pubmed: 35150882
Lancet. 1999 Sep 25;354(9184):1071-7
pubmed: 10509498
Clin Microbiol Infect. 2013 May;19(5):451-6
pubmed: 22563800
J Antimicrob Chemother. 2016 Jan;71(1):135-40
pubmed: 26462984
Open Forum Infect Dis. 2019 Jul 1;6(7):
pubmed: 31363779
Infect Drug Resist. 2020 May 05;13:1299-1305
pubmed: 32440167

Auteurs

B Hoellinger (B)

Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

S Deboscker (S)

Service d'Hygiène Hospitalière, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

F Danion (F)

Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

T Lavigne (T)

Service d'Hygiène Hospitalière, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.
Service de Réanimation Médicale de Hautepierre, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

F Severac (F)

Groupe Méthodes en Recherche Clinique (GMRC), Hôpital Civil, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

Y Ruch (Y)

Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

A Ursenbach (A)

Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

N Lefebvre (N)

Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

P Boyer (P)

Department of Bacteriology, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

Y Hansmann (Y)

Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourggrid.412220.7, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH